Amphenol Corporation (APH) Stock Forecasts

Erste Group initiated coverage on Amphenol (NYSE:APH) with a buy rating, citing strong demand, a 1.23 book-to-bill ratio, and 54% revenue growth. The company raised its Q3 revenue forecast to 51% YoY growth. Amphenol's Q2 2026 earnings beat estimates with $1.35 EPS and $8.8B revenue, up 55% YoY. Bernstein SocGen set a $99 price target, highlighting its market position.

Amphenol (NYSE: APH) shares rose 1.6% on Tuesday, outperforming the S&P 500, after two analysts raised their price targets. Goldman Sachs increased its target to $116, while Baird raised it to $105. Both maintained buy ratings, citing Amphenol's role in supplying components for AI data centers.

TTM Technologies (TTMI) and Amphenol (APH) have seen significant stock gains this year due to increased defense spending. TTM reported Q2 revenue of $1B (+37% YoY) and EPS of $0.77 (+92.5% YoY). Amphenol reported Q2 revenue of $8.8B (+55% YoY) and EPS of $1.37 (+59% YoY). Both companies benefit from defense electronics supply chain and AI infrastructure surges. They also have other revenue streams, with AI data center spending contributing significantly.

Amphenol (APH) reported strong Q2 2026 results, with IT datacom sales up 89% YoY, driven by AI-related demand. AI revenue run rate reached $10.5-$11B. CommScope acquisition added $1.2B in sales. Competitors TEL and MRVL also reported growth in AI-related segments. APH stock up 16% YTD, trading at 25.32x forward P/E. Earnings estimates revised up to 72 cents per share.

Citi analyst Asiya Merchant initiated a 90-day catalyst watch on Amphenol Corp (APH), maintaining a Buy rating with a $105 target price. The firm cited benefits from AI and data center investments. APH is trading at $83.92, 5.7% above its GF Value™ of $79.43, indicating slight overvaluation. The company has a GF Score™ of 97/100, reflecting strong profitability and growth. Insider activity shows net selling over the past 12 months.

Amphenol (APH) stock is down 18.3% from its 52-week high but up 46.5% over the past year, outperforming the Dow. Q2 2026 revenue rose 55% to $8.8B, beating estimates. Analysts rate it a 'Strong Buy' with a $200.50 price target. APH trades above its 200-day but below its 50-day moving average.